NeuroSense Therapeutics (NRSNW) Q2 2024 Earnings

24JunConfirmed
Dec 20
Mar 21
Jun 21
Q2 2024
-0.35
-0.23
-0.12
0

Details

Expected EPS
-0.205
Actual EPS
-0.35
Surprise EPS
-0.15
Surprise Percent
+70.73%

Description

NeuroSense Therapeutics (NRSNW) has reported earnings of -0.35 per share for Q2 2024.

0 Comments

Share your thoughts